Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085584 (
encephalopathy
)
18,178
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Analyses of the records of 120 patients who underwent portacaval shunting (PCS, 57%) or splenorenal shunting (
SRS
, 43%) from 1966-1973 disclosed that patients in each group undergoing elective shunts had the same preoperative physical condition and postoperative mortality rates (approximately 20%). Although the post-operative death rate from emergency shunts was 48%, patients having these procedures were poorer risks. Long-term incidences of
encephalopathy
were the same, irrespective of the type of shunt (PCS, 46%;
SRS
36%, P greater than 0.5). Despite comparisons of data most unfavorable for PCS, 5-year survival rates were also the same after either type of shunt (all PCS, 29 +/- 7.5%,
SRS
, 42.0 +/- 7.4%, P = 0.23). The survival rate after elective PCS was also the same as after
SRS
during the entire 5-year period. However, the survival after all elective PCS and
SRS
was significantly greater than after emergency PCS (P range = 0.005-0.038); the poorer results of emergency shunting could be partly attributed to the poorer condition of patients selected. A numerical score based on serum bilirubin concentrations, ascites, and urgency of shunting reliably predicts postoperative mortality. Long-term
encephalopathy
is predicted by a history of
encephalopathy
and the urgency of shunting.
...
PMID:Risks in therapeutic portacaval and splenorenal shunts. 96 96
From 1977 to 1983, 94 patients with esophageal varices and gastrointestinal bleeding secondary to mansonic schistosomiasis were entered into a prospective randomized trial comparing the three operations mainly used in Brazil: esophagogastric devascularization associated with splenectomy (EGDS, 32 patients), classical splenorenal shunt (
SRS
, 32 patients), and distal splenorenal shunt (DSRS, 30 patients). The randomization was interrupted because of a significant incidence of portosystemic
encephalopathy
(PSE) in the
SRS
group (26%), as compared to the DSRS (7%) and EGDS (0%) groups. The rate of rebleeding was the same in the three groups, but the rate of failure, as defined by the presence of technical problems, postoperative complications, or death, was significantly higher in the
SRS
group. This 2-year follow-up shows that
SRS
should be abandoned in hepatosplenic schistosomiasis and that a comparison between DSRS and EGDS with a longer follow-up is urgently needed.
...
PMID:A randomized trial for the study of the elective surgical treatment of portal hypertension in mansonic schistosomiasis. 309 Sep 54